Λέξεις-κλειδιά:
sorafenib, cancer chemotherapy; cancer patient; cancer prognosis; cancer recurrence; cancer staging; cancer surgery; chemoembolization; hospital mortality; human; liver cell carcinoma; liver resection; Note; overall survival; practice guideline; cancer staging; liver cell carcinoma; liver tumor; pathology; treatment outcome, Carcinoma, Hepatocellular; Hepatectomy; Humans; Liver Neoplasms; Neoplasm Staging; Treatment Outcome
